(Q38223237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Outcomes in the management of adult soft tissue sarcomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Jeffrey S Kneisl

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Chandrajit P Raut

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

25 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

Journal of Surgical Oncology

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

527-538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas

21 March 2020

cites work

1 reference

Outcome of soft-tissue sarcoma patients who were alive and event-free more than five years after initial treatment

21 January 2018

1 reference

Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

21 January 2018

1 reference

Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy

21 January 2018

1 reference

Effect of marital status on treatment and survival of extremity soft tissue sarcoma

21 January 2018

1 reference

Impact of margin status and local recurrence on soft-tissue sarcoma outcomes

21 January 2018

1 reference

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients

21 January 2018

1 reference

Why do patients with low-grade soft tissue sarcoma die?

21 January 2018

1 reference

Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients

21 January 2018

1 reference

Nonreferral of possible soft tissue sarcomas in adults: a dangerous omission in policy

21 January 2018

1 reference

Should Soft Tissue Sarcomas be Treated at a Specialist Centre?

21 January 2018

1 reference

Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline

21 January 2018

1 reference

A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma

21 January 2018

1 reference

Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy

21 January 2018

1 reference

Toward better soft tissue sarcoma staging: building on american joint committee on cancer staging systems versions 6 and 7.

21 January 2018

1 reference

Validation of the postoperative nomogram for 12-year sarcoma-specific mortality

21 January 2018

1 reference

A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation

21 January 2018

1 reference

A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients

21 January 2018

1 reference

Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome

21 January 2018

1 reference

Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.

21 January 2018

1 reference

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

21 January 2018

1 reference

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

21 January 2018

1 reference

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

21 January 2018

1 reference

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

21 January 2018

1 reference

Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome

21 January 2018

1 reference

Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery

21 January 2018

1 reference

Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group

21 January 2018

1 reference

Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system

21 January 2018

1 reference

Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets

21 January 2018

1 reference

Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution

21 January 2018

1 reference

Retroperitoneal sarcomas: grade and survival

21 January 2018

1 reference

Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.

21 January 2018

1 reference

Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience

21 January 2018

1 reference

Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival

21 January 2018

1 reference

Recurrent retroperitoneal sarcoma: impact of biology and therapy on outcomes

21 January 2018

1 reference

Treatment of localized sarcomas.

21 January 2018

1 reference

Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.

21 January 2018

1 reference

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas

21 January 2018

1 reference

Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram

21 January 2018

1 reference

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

21 January 2018

1 reference

Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up

21 January 2018

1 reference

Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

21 January 2018

1 reference

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

21 January 2018

1 reference

Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.

21 January 2018

1 reference

Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.

21 January 2018

1 reference

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors

21 January 2018

1 reference

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

21 January 2018

1 reference

Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.

21 January 2018

1 reference

Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate

21 January 2018

1 reference

Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).

21 January 2018

1 reference

The combination of surgery and imatinib in GIST: a reality for localized tumors at high risk, an open issue for metastatic ones.

21 January 2018

1 reference

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

21 January 2018

1 reference

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

21 January 2018

1 reference

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

21 January 2018

1 reference

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.

21 January 2018

1 reference

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

21 January 2018

1 reference

A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis

21 January 2018

1 reference

Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection

21 January 2018

1 reference

Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma G

21 January 2018

1 reference

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas

21 January 2018

1 reference

Gastrointestinal stromal tumors

21 January 2018

1 reference

Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity

21 January 2018

1 reference

Postoperative Nomogram for 12-Year Sarcoma-Specific Death

21 January 2018

1 reference

Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas

21 January 2018

1 reference

Is there a role for incomplete resection in the management of retroperitoneal liposarcomas?

21 January 2018

1 reference

Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

Lymph Node Metastasis in Soft Tissue Sarcoma in an Extremity

21 January 2018

1 reference

Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24965077%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference